Non Small Cell Lung Cancer

Showing NaN - NaN of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Cancer, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (TJ004309)

Recruiting
  • Ovarian Cancer
  • +5 more
  • Tucson, Arizona
  • +17 more
Jan 18, 2022

Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • GRT-C901
  • +3 more
  • Phoenix, Arizona
  • +10 more
Aug 31, 2021

Non Small Cell Lung Cancer, Cancer Trial in United States (Venetoclax, Pembrolizumab)

Terminated
  • Non Small Cell Lung Cancer
  • Cancer
  • Birmingham, Alabama
  • +38 more
Feb 10, 2021

Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Pembrolizumab)

Terminated
  • Non Small Cell Lung Cancer
  • Huntsville, Alabama
  • +73 more
Jan 15, 2021

Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Nivolumab)

Terminated
  • Non Small Cell Lung Cancer
  • Tempe, Arizona
  • +34 more
Aug 22, 2020

A Study of Personalized Neoantigen Cancer Vaccines

Completed
  • Non Small Cell Lung Cancer
  • +4 more
  • Blood collection for research (next-generation sequencing [NGS])
  • Blood collection for research (HLA typing)
  • Chicago, Illinois
  • +4 more
Sep 10, 2020

Non Small Cell Lung Cancer Trial in Worldwide (Pharmacokinetic sampling - AZD9291, AZD9291 tablet dosing, Rosuvastatin)

Completed
  • Non Small Cell Lung Cancer
  • Pharmacokinetic sampling - AZD9291
  • +4 more
  • Fairfax, Virginia
  • +12 more
Jul 2, 2018

Non Small Cell Lung Cancer Trial in Worldwide (Vandetanib, Erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Berkeley, California
  • +152 more
Jan 24, 2018

Non Small Cell Lung Cancer Trial in Worldwide (Mapatumumab, Paclitaxel, Carboplatin)

Completed
  • Non Small Cell Lung Cancer
  • Mapatumumab
  • +2 more
  • Birmingham, Alabama
  • +32 more
Aug 1, 2013